Prof. Dingwei Ye
Fudan University Cancer Hospital
China
Email: dwyeli@yahoo.com.cn
Qualifications
M.S., National Key Lab of Molecular Oncology, Shanghai Institute of Oncology, Shanghai, 1991~1992;
M.S., Department of pathophysiology and Radiation Medicine, SMMU, Shanghai, 1992~1993;
Associate Professor, Department of Urology, Changhai University, SMMU, Shanghai, 1999~2002;
Professor and Chairman, Department of Urology, Cancer Hospital, Fudan University, Shanghai, 2002
Selected Publications
CaoDL, YaoXD, YeDW,et alA multiplex model of combining gene-based, protein- based and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. Prostate, e-pub ahead of print 18 October 2010, DOI: 10.1002/pros.21286
Zhang HL, Yang LF, Zhu Y,et al. SerummiRNA-21:Elevated Levels in Patients With Metastatic Hormone-Refractory Prostate Cancer and Potential Predictive Factor for the Efficacy of Docetaxel-Based Chemotherapy. Prostate, e-pub ahead of print 18 October 2010
Qin XJ，YeDW，et al. Re: Jutta Engel, Patrick J. Bastian, Helmut Baur, et al. Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer. Eur Urol 2010,58(4), e43
Shi GH，YeDW，YaoXD，et al. Involvement of microRNA-21 in mediating chemoresistance to docetaxel in androgenindependentprostate cancer PC3 cells, APS,2010,31(7):867-873.
Zhu YP，Ye DW. Re: Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease. Clin Chim Acta,2010,41(23):2117.
Qin XJ, Ma CG, Ye DW, et al. Tumor cytoreduction results in better response to androgen ablation- a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer. Urologic Oncology: Seminars and Original Investigations.2010 May 5. [Epub ahead of print]
Dai B, Kong YY, Ye DW, Ma CG, Zhou X, Yao XD. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int. 2009, 104(7): 1009-1016.
Zhu YP, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Zhu Y, Shi GH.Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries.Asian J Androl. 2009 Jan;11(1):104-8.
Lin GW, Yao XD, Zhang SL, Dai B, Ma CG, Zhang HL, Shen YJ, Zhu Y, Zhu YP, Shi GH, Qin XJ, Ye DW.Prostate-specific antigen half-life: a new predictor of progression -free survival and overall survival in Chinese prostate cancer patients.Asian J Androl. 2009 Feb 2
Dai B, Kong YY, Ye DW, Ma CG，Zhou XY, Yao XD. HER2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy.Asian J Androl. 2008 Sep; 10(5): 701-9
Dai B, Ye DW, Kong YY, Shen YJ, Wang BH.Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.Asian J Androl. 2008 Mar;10(2):325-31.
Zhang HL,Ye DW, et al.Docetaxel plus Prednisone Versus Mitoxantrone plus Prednisone for Metastatic Hormone-Refractory Prostate Cancer in Chinese Patients: Experience of a Single Center.Urologia Internationalis 2007,79:307-311
Ye DW, Mendelsohn J, Fan Z. Augmentation of a humanized anti-HER mAb2 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225. Oncogene 1999;18:731
Ye DW, Mendelsohn J, Fan Z. Androgen and EGF downregulate cyclin-dependent kinase inhibitor p27kip1 and co-stimulate proliferation in two newly established prostatic cancer cell lines,MDA Pca2a and MDA Pca 2b. Clin Cancer Res, 1999, 5:2171-2177.
Zhu Y, Zhang SL, Ye DW, et al. Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report. Urol Int,2010,85(3):334-340.
Zhu Y, Zhang SL, Ye DW,et al. Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J Urol,2010,184(2):539-545.
Zhu Y, Zhang SL, Ye DW, et al. Repeat dynamic sentinel node biopsy in locally recurrent penile carcinoma. BJU Int.2010, 105(12):1732
Shi GH, YeDW, YaoXD, et al. Extramammary Paget’s diseases in men from theShanghai area: its association with PSA level increase. APMIS, 2010, 118(10): 777-781.
Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ.The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.J Urol.2008 Nov;180(5):2019-23.
Zhu Y , Zhou XY, Yao XD, Dai B, Ye DW. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int. 2007 Jul;100(1):204-8.
Zhu Y, Ye DW, Chen ZW, Zhang SL, Qin XJ. Frozen section-guided wide local excision in the treatment of penoscrotal extramammary Pagets disease. BJU Int. 2007 Dec;100(6):1282-7.
Zhu Y, Zhang SL, Ye DW, Yao XD, Jiang ZX, Zhou XY. Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquets node, and disease burden of inguinal lymph nodes. Onkologie. 2008 Feb;31(1-2):37-41.
Dai B, Ye DW, Kong YY, Yao XD, Zhang HL, Shen YJ. Predicting Regional Lymph Node Metastasis in Chinese Patients With Penile Squamous Cell Carcinoma: The Role of Histopathological classification, Tumor Stage and Depth of Invasion. J Urol. 2006 Oct;176(4 Pt 1):1431-5.
Zhang HL, Ye DW，et al. Role of KIT Expression in the Prognosis of Clear Cell Renal Cell Carcinomas in Chinese Patients. Journal of cancer research and clinical oncology.2009
Zhang HL, Dong BJ, Lu JJ, Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: results from a multicenter study. BMC Cancer. 2009 Jul 21;9:249.
Shen YJ,Ye DW,Yao XD,et al.Overexpression of CDC91L1（PIG-U）in bladder urothelial cell carcinoma: Correlation with clinical parameters and prognostic significance.BJU international. 2007 101(1)113~119.